Test eye drops for glaucoma or high eye pressure in both eyes
Part of Eyes & vision clinical trials.
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can sign consent and follow the study plan.
- You have chronic open-angle glaucoma or ocular hypertension in both eyes.
- Your eye pressure is between 22 and 35 (mm Hg) in each eye at the start (Day 0).
- You can stop or switch your current glaucoma eye drops and complete the required washout period before starting the study drop.
- Your vision in each eye is 20/100 or better (with best correction).
- If you can become pregnant, you must use effective birth control with no planned pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a bimatoprost implant placed during cataract surgery (combined with a special lens) can lower eye pressure better than standard timolol eye drops. It may help people with mild to moderate glaucoma or high eye pressure who are already planning cataract surgery.
This study tests whether three different eye drop treatments (netarsudil, latanoprost, or both together) can improve blood flow to the white part of the eye and the retina. It may help people with high eye pressure or who are glaucoma suspects better understand how these treatments work.
This trial tests a new implant that releases medicine for glaucoma while you have cataract surgery. It may help lower eye pressure without using daily drops.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
This study compares a new combination eye drop (Rocklatan) to a standard one (Latanoprost) to see how well they control eye pressure over 24 hours. It may help people with open-angle glaucoma or high eye pressure find a more effective treatment.
This trial tests a new eye drop combination (TFC-003) to lower eye pressure in people with primary open-angle glaucoma or ocular hypertension. It compares the new drug to existing treatments to see if it works better or is safer.
Hear when a new Glaucoma, Open-Angle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.